S.I. No. 258/2022 - Infectious Diseases (Amendment) Regulations 2022
Table of Provisions (7)
Statutory Text (7 Articles)
1. (1) These Regulations may be cited as the Infectious Diseases (Amendment) Regulations 2022.
(2) The Principal Regulations, the Infectious Diseases (Amendment) Regulations 1985 (
S.I. No. 268 of 1985
), the Infectious Diseases (Amendment) Regulations 1988 (
S.I. No. 288 of 1988
), the Infectious Diseases (Amendment) Regulations 1996 (
S.I. No. 384 of 1996
), the Infectious Diseases (Amendment) Regulations 2000 (
S.I. No. 151 of 2000
), the Infectious Diseases (Amendment) Regulations 2003 (
S.I. No. 115 of 2003
), the Infectious Diseases (Amendment) (No. 2) Regulations 2003 (
S.I. No. 180 of 2003
), the Infectious Diseases (Amendment) (No. 3) Regulations 2003 (
S.I. No. 707 of 2003
), the Infectious Diseases (Amendment) Regulations 2004 (
S.I. No. 865 of 2004
), the Infectious Diseases (Amendment) Regulations 2007 (
S.I. No. 559 of 2007
), the Infectious Diseases (Amendment) Regulations 2018 (
S.I. No. 567 of 2018
), the Regulations of 2020 and these Regulations may be cited as the Infectious Diseases Regulations 1981 to 2022.
2. In these Regulations—
“Principal Regulations” means the Infectious Diseases Regulations 1981 (
S.I. No. 390 of 1981
);
“Regulations of 2020” means the Infectious Diseases (Amendment) Regulations 2020 (
S.I. No. 53 of 2020
).
3. Regulation 8 (as amended by Regulation 3(a) of the Regulations of 2020) of the Principal Regulations is amended by inserting “Human monkeypox infection,” before “Influenza where it is Influenza of a new or re-emergent subtype”.
4. Regulation 14(1)(b) (as amended by Regulation 3(b) of the Regulations of 2020) of the Principal Regulations is amended by inserting “Human monkeypox infection,” before “Influenza where it is Influenza of a new or re-emergent subtype”.
5. Regulation 15(2)(a) (as amended by Regulation 3(c) of the Regulations of 2020) of the Principal Regulations is amended by inserting “Human monkeypox infection,” before “Influenza where it is Influenza of a new or re-emergent subtype”.
6. The Principal Regulations are amended by substituting for the Schedule (inserted by Regulation 3(d) of the Regulations of 2020) the following
“Schedule
Diseases specified to be infectious diseases and their respective causative pathogens
Disease
Causative Pathogen
Acute anterior poliomyelitis
Polio virus
Ano-genital warts
Human papilloma virus
Anthrax
Bacillus anthracis
Bacillus cereus food-borne infection/intoxication
Bacillus cereus
Bacterial meningitis (not otherwise specified)
Botulism
Clostridium botulinum
Brucellosis
Brucella species
Campylobacter infection
Campylobacter species
Carbapenemase producing enterobacteriaceae, infection or colonisation
Enterobacteriaceae
Chancroid
Haemophilus ducreyi
Chickenpox - hospitalised cases
Varicella-zoster virus
Chikungunya disease
Chikungunya virus
Chlamydia trachomatis infection (genital)
Chlamydia trachomatis
Cholera
Vibrio cholerae
Clostridium difficile infection
Clostridium difficile
Clostridium perfringens (type A) food- borne disease
Clostridium perfringens
Covid-19
SARS-CoV-2
Creutzfeldt Jakob disease
variant Creutzfeldt Jakob disease
Cryptosporidiosis
Cryptosporidium parvum, hominis
Cytomegalovirus infection (congenital)
Cytomegalovirus
Dengue Fever
Dengue Virus
Diphtheria
Corynebacterium diphtheriae or ulcerans (toxin producing)
Echinococcosis
Echinococcus species
Enterococcal bacteraemia
Enterococcus species (blood)
Escherichia coli infection (invasive)
Escherichia coli (blood, CSF)
Giardiasis
Giardia lamblia
Gonorrhoea
Neisseria gonorrhoeae
Granuloma inguinale
Klebsiella granulomatis
Haemophilus influenzae disease (invasive)
Haemophilus influenzae (blood, CSF or other normally sterile site)
Hepatitis A (acute) infection
Hepatitis A virus
Hepatitis B (acute and chronic) infection
Hepatitis B virus
Hepatitis C infection
Hepatitis C virus
Hepatitis E Infection
Hepatitis E virus
Herpes simplex (genital)
Herpes simplex virus
Herpes simplex (neonatal)
Herpes simplex virus
Human immunodeficiency virus infection
Human immunodeficiency virus
Human monkeypox infection
Monkeypox virus of the Orthopoxvirus genus
Influenza
Influenza A and B virus
Klebsiella pneumoniae infection (invasive)
Klebsiella pneumoniae (blood or CSF)
Legionellosis
Legionella species
Leprosy
Mycobacterium leprae
Leptospirosis
Leptospira species
Listeriosis
Listeria monocytogenes
Lyme disease (neuroborreliosis)
Borrelia burgdorferi
Lymphogranuloma venereum
Chlamydia trachomatis
Malaria
Plasmodium falciparum, vivax, knowlesi, ovale, malariae
mcr-positive Enterobacteriaceae infection or colonisation
Enterobacteriaceae
Measles
Measles virus
Meningococcal disease
Neisseria meningitidis
Mumps
Mumps virus
Non-specific urethritis
Novel or Rare Antimicrobial-resistant Organism (NRAO)
Noroviral infection
Norovirus
Paratyphoid
Salmonella Paratyphi
Pertussis
Bordetella pertussis
Plague
Yersinia pestis
Pseudomonas aeruginosa infection (invasive)
Pseudomonas aeruginosa (blood or CSF)
Q Fever
Coxiella burnetii
Rabies
Rabies virus
Respiratory syncytial virus infection
Respiratory syncytial virus
Rotavirus infection
Rotavirus
Rubella
Rubella virus
Salmonellosis
Salmonella spp other than S. Typhi and S. Paratyphi
Severe Acute Respiratory Syndrome (SARS)
SARS-associated coronavirus
Shigellosis
Shigella species
Smallpox
Variola virus
Staphylococcal food poisoning
Enterotoxigenic Staphylococcus aureus
Staphylococcus aureus bacteraemia
Staphylococcus aureus (blood)
Streptococcus group A infection (invasive)
Streptococcus pyogenes (blood, CSF or other normally sterile site)
Streptococcus group B infection (invasive)
Streptococcus agalactiae (blood, CSF, or other normally sterile site)
Streptococcus pneumoniae infection (invasive)
Streptococcus pneumoniae (blood, CSF or other normally sterile site)
Syphilis
Treponema pallidum
Tetanus
Clostridium tetani
Toxoplasmosis
Toxoplasma gondii
Trichinosis
Trichinella species
Trichomoniasis
Trichomonas vaginalis
Tuberculosis
Mycobacterium tuberculosis complex
Tularemia
Francisella tularensis
Typhoid
Salmonella Typhi
Typhus
Rickettsia prowazekii
Verotoxigenic Escherichia coli infection
Verotoxin producing Escherichia coli
Viral encephalitis
Viral haemorrhagic fevers
Viral meningitis
West Nile fever
West Nile virus
Yellow fever
Yellow fever virus
Yersiniosis
Yersinia enterocolitica, Yersinia pseudotuberculosis
Zika virus infection
Zika virus”.
GIVEN under my Official Seal,
25 May, 2022.
STEPHEN DONNELLY,
Minister for Health.
EXPLANATORY NOTE
(
This note is not part of the Regulation and does not purport to be a legal interpretation
)
These Regulations amend the Schedule to the Infectious Diseases Regulations 1981 (
S.I. No. 390 of 1981
) (“the Principal Regulations”) to include Human monkeypox infection amongst the list of diseases designated as an “infectious disease” for the purposes of the
Health Act 1947
. All diseases that are so designated are required to be notified (by a medical practitioner who becomes aware or suspects an instance of such disease) to a medical officer of health and are subsequently relayed to the HSE’s Health Protection Surveillance Centre in accordance with the Principal Regulations.
These Regulations also amend the Principal Regulations to provide for the inclusion of Human monkeypox infection amongst the list of infectious diseases that a person (who is a probable source of infection with the disease) may (as a necessary safeguard against the spread of the disease) be detained and isolated for, in accordance with the
Health Act 1947
. In addition, they provide for the preliminary notification (i.e. immediate notification by telephone) of Human monkeypox infection.
Notice of the making of this Statutory Instrument was published in
“Iris Oifigiúil” of
27
th May,
2022.
I, STEPHEN DONNELLY, Minister for Health, in exercise of the powers conferred on me by
sections 5
,
29
and
31
of the
Health Act 1947
(No. 28 of 1947), hereby make the following regulations